Why Exicure Inc. (XCUR) Soared on Monday
From Yahoo Finance: 2025-04-22 09:21:00
On Monday, the stock market saw heavy losses as investors reacted to President Trump’s tariff policies and Federal Reserve criticism. Nasdaq dropped 2.55%, Dow Jones 2.48%, and S&P 500 2.36%. Despite this, 10 micro- to small-cap companies managed gains, with Exicure Inc. (NASDAQ: XCUR) leading at 27.68%.
Exicure Inc. (NASDAQ: XCUR) rose 27.68% on Monday, closing at $11.30. The company’s subsidiary, GPCR Therapeutics USA, is near completion of a phase 2 study for GPC-100 in Multiple Myeloma, showing positive results in stem cell mobilization. XCUR is exploring strategic alternatives to maximize stockholder value.
XCUR ranks 10th among Monday’s top performers. While it shows promise, we believe AI stocks offer greater potential for higher returns in a shorter time frame. Check out our report on the cheapest AI stock with significant growth potential for a more promising investment opportunity.
Read more: Why Exicure Inc. (XCUR) Soared on Monday